Skip to Main Content

Paper Details

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR).
Cancer Med
20
2017
Author NameAffiliation
Oliver SartorTulane University School of Medicine
Zaina P QureshiThe Arnold School of Public Health, University of South Carolina
Dennis W RaischUniversity of New Mexico
Paul R YarnoldUniversity of South Carolina College of Pharmacy
Peter GeorgantopoulosUniversity of South Carolina College of Pharmacy
Charles L BennettUniversity of South Carolina College of Pharmacy
Charles L BennettThe Medical University of South Carolina Hollings Cancer Center
Charles L BennettWilliam Jennings Bryan Dorn Veterans Administration Medical Center
Charles L BennettUniversity of South Carolina College of Pharmacy
Charles L BennettThe Medical University of South Carolina Hollings Cancer Center
Charles L BennettWilliam Jennings Bryan Dorn Veterans Administration Medical Center
  • 1 - 11

Datasets

Release 1.2